ArticleCardiovascular and interventional radiology2025
Glue Penetration Index Score for Use during Glue Prostate Artery Embolization.
Article in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Maintaining Bilateral Arterial Catheters to Achieve Delayed Endpoint Embolization in Uterine Artery Embolization and Prostatic Artery Embolization: A Technical Perspective.Interventional radiology (Higashimatsuyama-shi (Japan) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo describe and test a scoring system for grading embolic penetration in prostate artery embolization (PAE). MATERIALS AND
methodsMulticenter retrospective study of 62 patients undergoing glue-PAE (n-butyl cyanoacrylate methacryloxysulfolane and ethiodized oil). Baseline angiograms and post-embolization radiographs were assessed by four consultant interventional radiologists on two occasions 6 weeks apart, grading depth and density of embolic, according to the described Glue Penetration Index Score (GPIS) and extended GPIS (eGPIS). GPIS (0-3) and eGPIS (0-3.5) scores of each hemigland were summed and whole-gland scores reported. Inter- and intra-observer variability were quantified. Clinical outcomes were assessed at 3 months.
resultsMean reduction in IPSS was 12.9 ± 8.2. Mean whole-gland GPIS was 4.1 ± 1.0 (16.1% ≤ 3; 83.9% > 3). Inter-observer agreement was moderate for GPIS (Fleiss' κ = 0.50, p < 0.0001) and fair for eGPIS (κ = 0.37, p < 0.0001). GPIS scores showed no significant intra-observer variability on repeat scoring (Cochran's Q, p = 0.39), whereas eGPIS did (p = 0.02). Only baseline IPSS correlated with 3-month clinical outcomes.
conclusionGPIS is a repeatable and reproducible score which may assist standardization of the description of extent of glue penetration during PAE in future studies.
Indexed as
Identifiers
40813473What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.